Carebox to present referral and disqualification frameworks at Boston conferences

Carebox Healthcare Solutions will present two clinical trial recruitment sessions in Boston on Sept. 14-16 at Partnerships with Sites and DPHARM. The company is pitching screen-failure and disqualification data as a way for sponsors to improve referrals, recruitment outcomes and visibility into why patients do not progress.

Why it matters: - Carebox is arguing that screen failures and disqualification data are not just operational leftovers. The company says they can help sponsors find the reasons recruitment stalls and improve how patients move into trials. - The two sessions target sponsor-site workflows and recruitment quality, two persistent pressure points in clinical development.

What happened: - Carebox Healthcare Solutions will present at two industry conferences in Boston: Partnerships with Sites on Sept. 14 and DPHARM on Sept. 15-16. - Caroline Melendez Daigle, Carebox VP of Services, will speak at Partnerships with Sites on Track 2 at 4:40 p.m. on Sept. 14. - Her session is titled “From Noise to Signal: Fixing the Referral Gap Between Sponsors and Sites.” - Brian Weiss, Carebox CEO, will speak at DPHARM on Sept. 15 in Track 1A, Session 42 at 11:55 a.m. - His session is titled “Explore the Path to Better Recruitment Outcomes with Disqualification Analysis.” - Carebox will exhibit at Booth #22 at Partnerships with Sites. - Carebox will also exhibit at Booth #517 in the Grand Ballroom Foyer Exhibits at DPHARM.

The details: - Melendez Daigle will present a model for improving referral quality and shared sponsor-site visibility. - The model is designed to avoid forcing sites to adopt new tools or route activity through a single platform. - Weiss will introduce DQA, short for Disqualification Analysis. - DQA maps screen failures back to their source. - The framework combines condition-based matching data, site outcomes and patient-reported barriers. - Carebox says the framework gives sponsors a view across studies, therapeutic areas, campaigns and vendors of why patients are not progressing and what to do about it. - Carebox describes itself as a clinical trial patient recruitment technology company focused on access to research-based treatment options and faster drug development. - The company says its platform connects patients and physicians with relevant clinical trials and addresses the primary bottleneck in clinical research recruitment.

Between the lines: - The messaging points to a broader shift in recruitment strategy: sponsors want more insight into where referrals break down, not just more leads. - The emphasis on shared visibility without extra site tooling suggests Carebox is positioning its framework as easier to adopt than traditional platform-heavy workflows. - By linking DQA to studies, therapeutic areas, campaigns and vendors, Carebox is framing disqualification analysis as a management tool, not only a metrics report.

What's next: - Carebox will use the Boston events to sell the idea that screen-failure data should guide recruitment decisions in real time. - The company’s conference presence will likely focus attention on its referral quality and DQA frameworks as part of its broader clinical trial engagement offering. - Interested attendees can learn more at Carebox’s website.

The bottom line: - Carebox is trying to turn screen failures into actionable recruitment intelligence for sponsors and sites.